tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ONCT Stock Latest News

Oncternal Therapeutics Faces Workforce Reduction Challenges: Potential Risks and Implications
Company AnnouncementsOncternal Therapeutics Faces Workforce Reduction Challenges: Potential Risks and Implications
2d ago
ONCT
Oncternal Therapeutics (ONCT) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Oncternal Therapeutics (ONCT) Q3 Earnings Cheat Sheet
5d ago
ONCT
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
16d ago
CUE
ALLK
Oncternal Therapeutics announces updated data from Phase 1/2 study of ONCT-534
PremiumThe Fly
Oncternal Therapeutics announces updated data from Phase 1/2 study of ONCT-534
18d ago
ONCT
Oncternal Therapeutics Restructures Amid Clinical Setbacks
PremiumCompany Announcements
Oncternal Therapeutics Restructures Amid Clinical Setbacks
2M ago
8K
ONCT
Oncternal Therapeutics downgraded to Market Perform from Outperform at Northland
PremiumThe FlyOncternal Therapeutics downgraded to Market Perform from Outperform at Northland
2M ago
ONCT
Oncternal Therapeutics downgraded to Hold from Buy at Brookline
Premium
The Fly
Oncternal Therapeutics downgraded to Hold from Buy at Brookline
2M ago
ONCT
Oncternal Therapeutics trading resumes
Premium
The Fly
Oncternal Therapeutics trading resumes
2M ago
ONCT
Oncternal terminates ONCT-534, ONCT-808 studies, explores strategic alternatives
PremiumThe Fly
Oncternal terminates ONCT-534, ONCT-808 studies, explores strategic alternatives
2M ago
ONCT
Oncternal Therapeutics trading halted, news pending
PremiumThe Fly
Oncternal Therapeutics trading halted, news pending
2M ago
ONCT
Oncternal Therapeutics price target lowered to $18 from $19 at H.C. Wainwright
PremiumThe Fly
Oncternal Therapeutics price target lowered to $18 from $19 at H.C. Wainwright
3M ago
ONCT
Oncternal Therapeutics reports Q2 EPS ($2.89 ), consensus ($3.10)
PremiumThe Fly
Oncternal Therapeutics reports Q2 EPS ($2.89 ), consensus ($3.10)
3M ago
ONCT
ONCT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsONCT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
ONCT
One new option listing and eighteen option delistings on July 22nd
Premium
The Fly
One new option listing and eighteen option delistings on July 22nd
4M ago
TIL
BKYI
Oncternal completes enrollment, dosing in Phase 1/2 study of ONCT-534
Premium
The Fly
Oncternal completes enrollment, dosing in Phase 1/2 study of ONCT-534
4M ago
ONCT
Oncternal: Enrollment complete in 1/2 Study of ONCT-534 to treat R/R PCa
PremiumThe Fly
Oncternal: Enrollment complete in 1/2 Study of ONCT-534 to treat R/R PCa
5M ago
ONCT
Oncternal Therapeutics price target lowered to $19 from $28 at H.C. Wainwright
PremiumThe Fly
Oncternal Therapeutics price target lowered to $19 from $28 at H.C. Wainwright
6M ago
ONCT
Oncternal Therapeutics reports Q1 EPS ($2.83), consensus ($2.88)
PremiumThe Fly
Oncternal Therapeutics reports Q1 EPS ($2.83), consensus ($2.88)
6M ago
ONCT
Oncternal Therapeutics reports inducement award under Nasdaq listing rule
PremiumThe Fly
Oncternal Therapeutics reports inducement award under Nasdaq listing rule
6M ago
ONCT
ONCT Earnings this Week: How Will it Perform?
PremiumPre-EarningsONCT Earnings this Week: How Will it Perform?
6M ago
ONCT
Oncternal announces first patient dosed in fourth cohort of study of ONCT-534
Premium
The Fly
Oncternal announces first patient dosed in fourth cohort of study of ONCT-534
7M ago
ONCT
Oncternal Therapeutics price target lowered to $28 from $30 at H.C. Wainwright
Premium
The Fly
Oncternal Therapeutics price target lowered to $28 from $30 at H.C. Wainwright
7M ago
ONCT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >